Oruka Therapeutics, Inc. (ORKA) Shareholders’ equity 2016–2023
Oruka Therapeutics, Inc. (ORKA) shareholders’ equity at each fiscal year-end, per SEC filings.
$37.0MFY2023 · since FY2016: $22.2M → $37.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | $37.0M | -11.2% |
| FY2022 | $41.7M | -18.4% |
| FY2021 | $51.0M | +9.7% |
| FY2020 | $46.5M | +511.3% |
| FY2019 | $7.6M | +26.2% |
| FY2018 | $6.0M | -41.3% |
| FY2017 | $10.3M | -53.7% |
| FY2016 | $22.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice